Latest Commercial Readiness News

Viridis Mining and Minerals completes a Definitive Feasibility Study for its Colossus Rare Earth Project, confirming strong economics and project readiness, while securing $120 million in equity funding to advance into execution.

Podium Minerals has secured a $4 million underwritten share purchase plan to fund advancing metallurgical work and site rehabilitation at its Parks Reef PGM Project, following a significant step-change in concentrator performance.

Clarity Pharmaceuticals bolsters its commercial readiness with a $178.3 million cash reserve and a key US manufacturing agreement, while clinical trials for its prostate cancer imaging and therapeutic agents progress with promising data.

Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial stays on track for November topline results, buoyed by strong open-label extension enrolment and aligned EMA-FDA regulatory advice. A new antidepressant study publication and fresh patents add momentum, supported by a $16.7 million cash runway to mid-2027.

Island Pharmaceuticals has marked a major step forward in its antiviral program with the start of GMP manufacturing for Galidesivir, expanded USAMRIID collaboration, and FDA orphan drug designation. Regulatory approvals for compassionate use in Uganda’s Ebola outbreak and a new dose optimisation study with Texas Biomed further de-risk the pathway to approval.

Metallium has validated its Flash Joule Heating technology through extensive testing and multi-reactor operation, advancing towards commercial e-waste processing at its Texas campus in H1 2027.

Aeeris Ltd has boosted its Annual Recurring Revenue by 9.1% year-on-year to $3.84 million, driven by an 18.6% rise in fixed subscription revenue and a strategic shift towards enterprise clients.

Paradigm Biopharmaceuticals has secured US$3 million in its latest tranche under a US$27 million convertible note facility, bolstering funding for its global Phase 3 trial of injectable pentosan polysulfate sodium in knee osteoarthritis.

Pure Resources has achieved peer-reviewed validation and in-house production of carbon nanotube fibre fabrics, demonstrating directional heat routing capabilities that could redefine thermal management in data centres and defence electronics.

Nanoveu has completed its acquisition of Singapore’s Spinoff Robotics, gaining validated drone platforms and engineering talent to fast-track its ECS-DoT edge-AI silicon integration for advanced aerial applications.

Environmental Clean Technologies (ASX: ECT) has submitted detailed data to the US EPA showcasing its Rapid Electrothermal Mineralisation (REM) technology's ability to destroy PFAS with over 99% efficacy and full fluorine mass balance, aiming to meet stringent regulatory standards.

dorsaVi reveals that integrating RRAM and neuromorphic computing into its sensor platform could halve sensor count and more than double battery life in lower-limb exoskeletons, positioning the company as a key intelligence partner in a $1.79 billion market.